Colorectal Cancer Management and Prevention Using Plant Polyphenols
in the Rodent Models
Dongbo Liu1#, Le Huang2#, Quan Zhou3
and Yan Meng4*
1Cancer
Center, Tongji Hospital, Tongji Medical College, Huazhong University
of Science and Technology, Wuhan, Hubei, China; 2Department
of Oncology, Tongji Hospital, Tongji Medical College, Huazhong
University of Science and Technology, Wuhan, Hubei, China; 3Department
of General Surgery, Yingkou People's Hospital, Yingkou, Liaoning,
China; 4Departments of General Surgery, The Second
Hospital of Dalian Medical University, Dalian, Liaoning, China.
*Corresponding author:
mengyan0411@163.com
Abstract
Colorectal cancer is
among the most common and deadliest types of cancers affecting humans and
animals. Currently, chemotherapeutic and radiotherapeutic measures are being
practiced in treating it but they have devastating side effects including
cardiopathologies and nephropathologies.
Moreover, they are unreliable and can not provide complete treatment in advanced
cases. These scenarios necessitate therapeutic substances for the prevention and
treatment of colorectal cancer. Plant-based compounds, especially various types
of phenolics are among the most considered substances as alternatives to prevent
and treat colorectal cancer. Among all the phenolics, multiple compounds
belonging to flavonoids, flavone, flavonol, and stilbenes have been found
effective in treating and preventing colorectal cancer. Predisposing factors
that lead to the development of colorectal cancer depend upon living type,
feeding type, genotype, age, gender, and exposure to carcinogens. All the
polyphenolics prevent colorectal cancer by detoxifying carcinogens, oxidative
stress management, reduction in preneoplastic lesions. Specifically, quercetin
can arrest S, G1/S, and other stages of cancerous cells, resveratrol controls
cancerous cell proliferation and detoxifies the pathological effects of
anticancer therapeutic agents by regulating several enzyme systems, and
kaempferols control aging process, and uncontrolled metastasis by regulating
relevant enzyme systems. All these polyphenolics arrest cancer metastasis by
limiting abnormal cell division, preventing extracellular skeletal system
damage, and several other pathways. Additionally, they have been found safe for
all the systems of the body which is their advantage over current cancer
therapies.All of these have passed in
vitro trials and proven effective. Currently, xenograft rodent models are
being used and these in vivo models also approve their therapeutic use of
some polyphenolics i.e., resveratrol and kaempferol are being clinically used as
synergists to chemotherapeutic substances. This review highlights the potential
of selected polyphenolics as preventive and cancer-treating substances in the
light of in vivo studies in rodent models.
To Cite This Article:
Liu D, Huang L, Zhou
Q, Meng Y, 2024. Colorectal cancer management and prevention using plant
polyphenols in the rodent models. Pak Vet J, 44(3): 571-580.
http://dx.doi.org/10.29261/pakvetj/2024.231